A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, placebo-controlled, parallel-group study will evaluate the
safety and pharmacokinetics of subcutaneous lebrikizumab in healthy Japanese volunteers.
Healthy Japanese and Caucasian volunteers will be randomized to receive a single subcutaneous
dose of either lebrikizumab or placebo.